Want to join the conversation?
Healthcare company $JNJ said Janssen Biotech has submitted a supplemental Biologics License Application (sBLA) for daratumumab to the US FDA. The application seeks to expand the current indication, using daratumumab in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.